Fulcrum Therapeutics, Inc.
FULC- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001680581
In the last 90 days, Fulcrum Therapeutics, Inc. insiders filed 2 open-market purchases and 0 sales; 154 institutions reported holding it in 13F filings for Q2 2026, worth $291.3M in total; no superinvestor holds it.
Q1 2025 vs. Q4 2024
How the institutions holding Fulcrum Therapeutics, Inc. changed between Q4 2024 and Q1 2025.
All holders in Q1 2025All holders in Q4 2024
| Measure | Q4 2024 | Of which not filed for Q1 2025 | Q1 2025 | Change |
|---|---|---|---|---|
| Holders | 119 | 1 | 117 | −1 |
| Shares | 51.7M | 169.5K | 51.4M | −189.6K (−0.4%) |
| Value | $243.4M | $796.9K | $147.8M | −$94.8M (−39.1%) |
1 institution that held it in Q4 2024 haven't filed for Q1 2025 yet. Not filing isn't selling, so the changes leave them out.
New holders (18)
Institutions that held Fulcrum Therapeutics, Inc. at the end of Q1 2025 but not at the end of Q4 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Renaissance Technologies LLC | 401,100 | $1.16M | 0.00% |
| Catalio Capital Management, LP | 202,139 | $582.2K | 0.14% |
| Nuveen, LLC | 152,992 | $440.6K | 0.00% |
| Jacobs Levy Equity Management, Inc | 147,654 | $425.2K | 0.00% |
| Cubist Systematic Strategies, LLC | 57,070 | $164.4K | 0.00% |
| XTX Topco Ltd | 49,878 | $143.6K | 0.01% |
| Y-Intercept (Hong Kong) Ltd | 32,086 | $92.4K | 0.01% |
| Virtu Financial LLC | 13,564 | $39.0K | 0.00% |
| Engineers Gate Manager LP | 12,519 | $36.1K | 0.00% |
| CIBC World Markets Corp | 11,949 | $34.4K | 0.00% |
| Jump Financial, LLC | 10,550 | $30.4K | 0.00% |
| JustInvest LLC | 10,266 | $29.6K | 0.00% |
| US Bancorp | 2,100 | $6.05K | 0.00% |
| Farther Finance Advisors, LLC | 2,021 | $5.58K | 0.00% |
| UBS Asset Management Americas Inc | 703 | $2.02K | 0.00% |
| Rialto Wealth Management, LLC | 159 | $458 | 0.00% |
| Coldstream Capital Management Inc | 105 | $302 | 0.00% |
| True Wealth Design, LLC | 10 | $29 | 0.00% |
Sold out (19)
Institutions that held Fulcrum Therapeutics, Inc. at the end of Q4 2024 and filed for Q1 2025 without it.
| Institution | Shares, Q4 2024 | Value, Q4 2024 |
|---|---|---|
| Perceptive Advisors LLC | 238,000 | $1.12M |
| Wellington Management Group LLP | 172,158 | $809.1K |
| State Board of Administration of Florida Retirement System | 130,693 | $614.3K |
| Mackenzie Financial Corp | 118,025 | $554.7K |
| LMR Partners LLP | 112,500 | $528.8K |
| Altium Capital Management LP | 111,812 | $525.5K |
| Nebula Research & Development LLC | 75,140 | $353.2K |
| MYDA Advisors LLC | 63,970 | $300.7K |
| Bailard, Inc. | 35,900 | $168.7K |
| Corton Capital Inc. | 23,498 | $110.4K |
| Cantor Fitzgerald, L. P. | 20,000 | $94.0K |
| Mariner, LLC | 16,516 | $77.6K |
| Winton Group Ltd | 12,997 | $61.1K |
| Belvedere Trading LLC | 758 | $3.56K |
| C M Bidwell & Associates Ltd | 117 | $550 |
| HighMark Wealth Management LLC | 100 | $470 |
| Advisor Group Holdings, Inc. | 95 | $447 |
| Larson Financial Group LLC | 15 | $71 |
| Zurcher Kantonalbank (Zurich Cantonalbank) | 3 | $14 |
Not filed for Q1 2025 yet (1)
Institutions that held Fulcrum Therapeutics, Inc. at the end of Q4 2024 and haven't filed a 13F for Q1 2025. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q4 2024 | Value, Q4 2024 |
|---|---|---|
| Nuveen Asset Management, LLC | 169,549 | $796.9K |